Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Induction and enhancement of antitumor immunity involving Sindbis virus vectors expressing immune checkpoint proteins

Induction and enhancement of antitumor immunity involving Sindbis virus vectors expressing immune checkpoint proteins

US Patent 12097257 · Granted Sep 24, 2024

Estimated economic value: $1,024,124,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Induction and enhancement of antitumor immunity involving virus vectors expressi2024
Induction and enhancement of antitumor immunity involving virus vectors expressi2024
Induction and enhancement of antitumor immunity involving virus vectors expressi2024
Induction and enhancement of antitumor immunity involving virus vectors expressi2024
Method for inducing antitumor immunity using Sindbis viral vectors and tumor ass2018
Defective Sindbis viral vector comprising an anti-tumor gene2013
Tumor therapy with replication competent sindbis viral vectors2012
Human laminin receptor crystal and uses thereof2012
Defective sindbis viral vectors2012
Method for detecting cancer cells and monitoring cancer therapy2011
Tumor therapy with high affinity laminin receptor-targeted vectors2010
Packaging cell lines for the continuous production of alphavirus vectors2008